Global Neurostimulation/Neuromodulation Market

The global Neurostimulation/Neuromodulation market is driven by aging population and associated diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. The market value is expected to reach from $4,503.9 to $7,810.4 million from 2013 to 2018, at a CAGR of 11.60%. The market value is expected to grow due to technical advances and patient-friendly techniques which are minimally invasive and non-invasive. The neurostimulation/neuromodulation market is the largest market with a share of 96% of the total nerve repair and regeneration market.

The report “Neurostimulation/Neuromodulation Market Forecast, 20012-2018”, analyzes the market into two types of neuromodulation such as internal and external. The market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external stimulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS).

The segmentation experienced a positive growth till 2013 with an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $3.9 and $0.6 billion, internal and external neuromodulation accounted around 87% and 13% share in terms of value towards total neuromodulation device. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of SCS, DBS, VNS, SNS, GES, TMS, and TENS.

Procedure volume growth is higher in BIC (Brazil, India, and China) and Mexico because of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people.

According to the International Neurostimulation Society, about 40-50 million patients worldwide suffer from epilepsy and 1.5 million from Parkinson’s in the U.S. alone. A wide pool of patients suffering from other conditions such as depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor are also an influential factor in triggering the market towards growth. Treatment for tinnitus represents one of the emerging applications in this market. According to the American Tinnitus Association, about 50 million people suffer from the disease in the U.S. alone.

The prevalence of Alzeimer’s in Europe and North America is around 6.4-5.4% in adult population whereas in Asia, it is around 4%. The prevalence in Asia is because of maximum aging population whereas in North America and Europe it’s because of obese population and diabetes. The incidence of Alzheimer’s was estimated to be 411,000 in 2000. This was expected to increase to 454,000 in 2010, 615,000 by 2030 and 959,000 by 2050. Such high incidence rates in neurological disorders will positively affect the market for neuromodulation.

The report provides an extensive competitive landscaping of companies operating in this market. Major players of the market covered in the report are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), EnteroMedics, Inc. (U.S.), Dynatronics Corporation (U.S.), and Neuronetics (U.S.). Some emerging players of the market are Functional Neuromodulation,Ltd (U.S.), MicroTransponder,Inc. (U.S.), Zynex Medical, Inc. (U.S.), and Neurotech SA (Belgium). The details of segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is covered in the report.

Customization Options

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:

Product Analysis

• Usage pattern (in-depth trend analysis) of products (segment-wise)
• Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
• End-user adoption rate analysis of the products (segment and country wise)
• Comprehensive coverage of product approvals, pipeline products, and product recalls

Epidemiology Data

• Country-specific prevalence, incidence, and patient pool of Alzheimer’s ,Parkinson’s, epilepsy,and stroke
• Country-specific mortality rate of stroke and epilepsy
• Disease progression (pattern analysis)

Procedure Volume Data

• Number of surgeries for epilepsy, heart failure, Alzheimer’s and Parkinson’s country wise

Surgeons/Physicians Perception Analysis

• Fast turn-around analysis of surgeons response to market events and trends
• Pattern analysis of usage of spinal cord stimulation (SCS), deep brain stimulation (DBS) by physicians
• Surgeon’s opinion about products from different companies
• Surgeon’s qualitative inputs on epidemiology data

Brand/Product Perception Matrix

• Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
• Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

Pricing Trends

• Cost analysis of Neurostimulation/Neuromodulation devices in major countries
• Internal Neurostimulation/Neuromodulation procedural investment in major countries

Competitive Intelligence

• The company share analysis for the top players of the Neurostimulation/Neuromodulation market in the region
• The crucial developments and strategies of companies inculcating in their portfolio for Neurostimulation/Neuromodulation

Table Of Contents

1 Introduction (Page No. - 9)
    1.1 Objectives Of The Study 
    1.2 Market Segmentation & Coverage 
    1.3 Stakeholders 
2 Research Methodology (Page No. - 11)
    2.1 Integrated Ecosystem Of Internal Neurostimulation/ Neuromodulation Market 
    2.2 Arriving At The Neuromostimulation/Neuromodulation Market Size 
           2.2.1 Market Share
           2.2.2 Top-Down Approach
3 Executive Summary (Page No. - 13)
4 Market Overview (Page No. - 15)
    4.1 Introduction 
    4.2 Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market 
    4.3 Market Drivers And Inhibitors 
5 Internal Neurostimulation/Neuromodulation Market, By Modality (Page No. - 20)
    5.1 Introduction 
    5.2 Spinal Cord Stimulation 
    5.3 Deep Brain Stimulation 
    5.4 Sacral Nerve Stimulation 
    5.5 Vagus Nerve Stimulaton 
    5.6 Gastric Electrical Stimulation (GES) 
6 Internal Neurostimulation/Neuromodulation Market, By Application (Page No. - 33)
    6.1 Introduction 
           6.1.1 Spinal Cord Stimulation (SCS) Market, By Application/ Geography
                    6.1.1.1 Spinal Cord Stimulation (SCS) Market, By Application
                    6.1.1.2 Spinal Cord Stimulation (SCS) Market, By Geography
           6.1.2 Deep Brain Stimulation (DBS) Market, By Application/ Geography
                    6.1.2.1 Deep Brain Stimulation (DBS) Market, By Application
                    6.1.2.2 Deep Brain Stimulation (DBS) Market, By Geography
           6.1.3 Sacral Nerve Stimulation (SNS) Market, By Application/ Geography
                    6.1.3.1 Sacral Nerve Stimulation (SNS) Market, By Application
                    6.1.3.2 Sacral Nerve Stimulation (SNS) Market, By Geography
           6.1.4 Vagus Nerve Stimulation (Vns) Market, By Application/Geography
                    6.1.4.1 Vagus Nerve Stimulation (Vns) Market, By Application
                    6.1.4.2 Vagus Nerve Stimulation (Vns) Market, By Geography
           6.1.5 Gastric Electrical Stimulation (GES) Market, By Application/ Geography
                    6.1.5.1 Gastric Electrical Stimulation (GES) Market, By Application
                    6.1.5.2 Gastric Electrical Stimulation (GES) Market, By Geography
7 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape (Page No. - 63)
    7.1 Company Share Analysis: By Modality 
           7.1.1 Spinal Cord Stimulation
           7.1.2 Deep Brain Stimulation
           7.1.3 Sacral Nerve Stimulation
           7.1.4 Vagus Nerve Stimulation
    7.2 Company Presence In Internal Neurostimulation/ Neuromodulation Market 
8 Internal Neurostimulation/Neuromodulation Market, By Company (Page No. - 69)
(Overview, Financials, Products & Services, Strategy, And Developments)*
    8.1 Boston Scientific Corporation (U.S.) 
    8.2 Cerbomed Gmbh (Germany) 
    8.3 Cyberonics, Inc. (U.S.) 
    8.4 Enteromedics, Inc. (U.S.) 
    8.5 Medtronic, Inc. (U.S.) 
    8.6 St. Jude Medical (U.S.) 
    8.7 Synapse Biomedical, Inc. (U.S.) 
    8.8 Uroplasty, Inc. (U.S.) 
*Details On Overview, Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Company
9 Appendix (Page No. - 82)
    9.1 Customization Options 
           9.1.1 Product Analysis
           9.1.2 Epidemiology Data
           9.1.3 Surgeons/Physicians Perception Analysis
           9.1.4 Regulatory Framework
    9.2 Related Reports 
    9.3 Introducing Rt: Real-Time Market Intelligence 
           9.3.1 Snapshots

List Of Tables 
 
Table 1 Global Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market, 2012 – 2019 (USD Million)
Table 2 Internal Neuromodulation/Neurostimulation Market, By Geography, 2012 – 2019 (USD Thousand)
Table 3 Internal Neuromodulation/Neurostimulation Market In Saudi Arabia, South Africa, And Turkey: Drivers And Inhibitors
Table 4 Internal Neurostimulation/Neuromodulation Market In South Africa, By Modality, 2013 - 2019 (USD Thousand) 
Table 5 Internal Neurostimulation/Neuromodulation Market In Turkey, By Modality, 2012 – 2019 (USD Thousand) 
Table 6 Internal Neurostimulation/Neuromodulation Market In Saudi Arabia, By Modality, 2012 – 2019 (USD Thousand) 
Table 7 Spinal Cord Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Table 8 Deep Brain Stimulation Market, By Geography, 2012–2019 (USD Thousand)
Table 9 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Table 10 Vagus Nerve Stimulation Market, By Geography, 2012–2019 (USD Mn)
Table 11 Gastric Electrical Stimulation Masks Market, By Geography, 2013–2019 (USD Thousand) 
Table 12 Spinal Cord Stimulation (SCS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Table 13 Spinal Cord Stimulation (SCS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 14 Spinal Cord Stimulation (SCS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 15 Chronic Pain Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 16 Failed Back Surgery Syndrome Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 17 Ischemia Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 18 Deep Brain Stimulation (DBS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Table 19 Deep Brain Stimulation (DBS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 20 Deep Brain Stimulation (DBS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 21 Parkinson’s Disease Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 22 Tremor Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 23 Depression Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2013 - 2019 (USD Thousand)
Table 24 Sacral Nerve Stimulation (SNS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Table 25 Sacral Nerve Stimulation (SNS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 26 Sacral Nerve Stimulation (SNS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand)
Table 27 Urinary Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 28 Fecal Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 29 Vagus Nerve Stimulation (Vns) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Table 30 Vagus Nerve Stimulation (Vns) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 31 Vagus Nerve Stimulation (Vns) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 32 Epilepsy Segment In Vagus Nerve Stimulation (Vns) Market, By Geography, 2012 – 2019 (USD Thousand)
Table 33 Gastric Electrical Stimulation (GES) Market In South Africa, By Application, 2012- 2019 (USD Thousand) 
Table 34 Gastric Electrical Stimulation (GES) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Table 35 Gastric Electrical Stimulation (GES) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Table 36 Gastroparesis Segment In Gastric Electrical Stimulation (GES) Market, By Geography, 2012 – 2019 (USD Thousand) 
Table 37 Boston Scientific Corporation: Key Financials, By Segments, 2009 – 2013 (USD Million) 
Table 38 Boston Scientific: Key Financials, By Geography, 2009 – 2012 (USD Million)
Table 39 Cyberonics, Inc.: Key Financials, 2009 - 2013 (USD Million)
Table 40 Medtronic, Inc. : Key Financials, By Segments, 2009 - 2013 (USD Million)
Table 41 Medtronic, Inc. : Key Financials, 2009 - 2013 (USD Million)
Table 42 St. Jude Medical: Key Financials, By Segments, 2011 - 2013 (USD Million)
Table 43 St. Jude Medical: Key Financials, By Geography, 2008 - 2013 (USD Million)
Table 44 Uroplasty, Inc. : Key Financials, By Geography, 2011 - 2013 (USD Million)
 
 
List Of Figures 
 
Figure 1 Neurostimulation/Neuromodulation Market In Saudi Arabia, South Africa, And Turkey: Segmentation & Coverage 
Figure 2 Internal Neurostimulation/Neuromodulation Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Global Internal Neurostimulation/Neuromodulation Market: Comparison With Parent Market, 2012 – 2018 (USD Million)
Figure 5 Internal Neuromodulation/Neurostimulation Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 6 Internal Neurostimulation/Neuromodulation Market In South Africa, By Modality, 2013–2019 (USD Thousand) 
Figure 7 Internal Neurostimulation/Neuromodulation Market In Turkey, By Modality, 2013–2019 (USD Thousand) 
Figure 8 Internal Neurostimulation/Neuromodulation Market In Turkey, By Modality, 2013–2019 (USD Thousand) 
Figure 9 Spinal Cord Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 10 Deep Brain Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 11 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 12 Vagus Nerve Stimulation Market, By Geography, 2013–2019 (USD Mn)
Figure 13 Gastric Electrical Stimulation Masks Market, By Geography, 2013–2019 (USD Thousand) 
Figure 14 Spinal Cord Stimulation (SCS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Figure 15 Spinal Cord Stimulation (SCS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 16 Spinal Cord Stimulation (SCS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Figure 17 Chronic Pain Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 18 Failed Back Surgery Syndrome Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 19 Ischemia Segment In Spinal Cord Stimulation (SCS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 20 Deep Brain Stimulation (DBS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Figure 21 Deep Brain Stimulation (DBS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 22 Deep Brain Stimulation (DBS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Figure 23 Parkinson’s Disease Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 24 Tremor Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 25 Depression Segment In Deep Brain Stimulation (DBS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 26 Sacral Nerve Stimulation (SNS) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Figure 27 Sacral Nerve Stimulation (SNS) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 28 Sacral Nerve Stimulation (SNS) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand)
Figure 29 Urinary Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 30 Fecal Incontinence Segment In Sacral Nerve Stimulation (SNS) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 31 Vagus Nerve Stimulation (Vns) Market In South Africa, By Application, 2012 – 2019 (USD Thousand)
Figure 32 Vagus Nerve Stimulation (Vns) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 33 Vagus Nerve Stimulation (Vns) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand) 
Figure 34 Epilepsy Segment In Vagus Nerve Stimulation (Vns) Market, By Geography, 2012 – 2019 (USD Thousand)
Figure 35 Gastric Electrical Stimulation (GES) Market In South Africa, By Application, 2012 – 2019 (USD Thousand) 
Figure 36 Gastric Electrical Stimulation (GES) Market In Turkey, By Application, 2012 – 2019 (USD Thousand) 
Figure 37 Gastric Electrical Stimulation (GES) Market In Saudi Arabia, By Application, 2012 – 2019 (USD Thousand)
Figure 38 Gastroparesis Segment In Gastric Electrical Stimulation (GES) Market, By Geography, 2012 – 2019 (USD Thousand) 
Figure 39 South Africa : Spinal Cord Stimulation , By Company, 2014
Figure 40 Saudi Arabia : Spinal Cord Stimulation , By Company, 2014
Figure 41 Turkey : Spinal Cord Stimulation , By Company, 2014
Figure 42 South Africa : Deep Brain Stimulation , By Company, 2014
Figure 43 Saudi Arabia : Deep Brain Stimulation , By Company, 2014
Figure 44 Turkey : Deep Brain Stimulation , By Company, 2014
Figure 45 South Africa : Vagus Nerve Stimulation , By Company, 2014
Figure 46 Saudi Arabia : Vagus Nerve Stimulation , By Company, 2014
Figure 47 Turkey : Vagus Nerve Stimulation , By Company, 2014
Figure 48 Internal Neurostimulation/ Neuromodulation Market: Company Coverage, By Product, 2013

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :Global Neurostimulation/Neuromodulation Market

* Enter the text from the image to the text box :